 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 04/18/2024 |
$11.77 |
$11.90 |
$11.17 |
$11.30 |
151.30K | | 04/19/2024 |
$11.50 |
$11.50 |
$9.94 |
$10.09 |
160.30K | | 04/22/2024 |
$9.90 |
$10.61 |
$9.83 |
$10.01 |
184.10K | | 04/23/2024 |
$9.97 |
$10.90 |
$9.97 |
$10.66 |
111.70K | | 04/24/2024 |
$10.86 |
$11.21 |
$10.03 |
$11.03 |
158.70K |
|
|
| Audentes Therapeutics is a clinical stage biotechnology company focused on developing and commercializing gene therapy products for patients living with serious, life-threatening rare diseases caused by single gene defects. Co. has a portfolio of product candidates, including AT132 for the treatment of X-Linked Myotubular Myopathy, AT845 for the treatment of Pompe disease, AT342 for the treatment of Crigler-Najjar Syndrome, and AT307 for the treatment of the CASQ2 subtype of Catecholaminergic Polymorphic Ventricular Tachycardia. Co. focuses on the treatment of rare diseases caused by single gene, or monogenic, defects in DNA that can be addressed using gene therapy. | |
|
Boundless Bio (BOLD) has the following price history information. Looking back at BOLD historical stock prices for the last five trading days, on April 18, 2024, BOLD opened at $11.77, traded as high as $11.90 and as low as $11.17, and closed at $11.30. Trading volume was a total of 151.30K shares. On April 19, 2024, BOLD opened at $11.50, traded as high as $11.50 and as low as $9.94, and closed at $10.09. Trading volume was a total of 160.30K shares. On April 22, 2024, BOLD opened at $9.90, traded as high as $10.61 and as low as $9.83, and closed at $10.01. Trading volume was a total of 184.10K shares. On April 23, 2024, BOLD opened at $9.97, traded as high as $10.90 and as low as $9.97, and closed at $10.66. Trading volume was a total of 111.70K shares. On April 24, 2024, BOLD opened at $10.86, traded as high as $11.21 and as low as $10.03, and closed at $11.03. Trading volume was a total of 158.70K shares.
BOLD Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Boundless Bio shares, starting with a $10,000 purchase of BOLD, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
03/28/2024 |
|
| End date: |
04/24/2024 |
|
| Start price/share: |
$14.25 |
|
| End price/share: |
$11.03 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-22.60% |
|
| Annualized Gain: |
-305.47% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$7,740.00 |
|
| Years: |
0.07 |
|
|
|
| Date |
Close |
| 04/18/2024 | $11.30 | | 04/19/2024 | $10.09 | | 04/22/2024 | $10.01 | | 04/23/2024 | $10.66 | | 04/24/2024 | $11.03 |
|
|
Free BOLD Email Alerts:
